AMLX
Amylyx Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $1.28B | Price | $13.93 |
| Volume | 1.02M | Change | -0.85% |
| P/E Ratio | -4.2 | Open | $14.01 |
| Revenue | $87.4M | Prev Close | $14.05 |
| Net Income | $-301.7M | 52W Range | $2.60 - $16.96 |
| Div Yield | N/A | Target | $18.50 |
| Overall | 59 | Value | 60 |
| Quality | -- | Technical | 58 |
No chart data available
Stock Overview
Updated DailyAmylyx Pharmaceuticals Inc. (AMLX) is a leading diversified company in the business industry, currently trading at $13.93 with a market capitalization of $1.28 billion. The stock is positioned in the upper portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows AMLX with a volume of 1.02 million shares. The stock opened down 0.28% from yesterday's close of $14.05. Current analyst estimates project earnings of $-1.58 per share for this year, with next year targeting $-1.23.
AMLX demonstrates neutral technical outlook based on technical analysis. The company trades on the NGS exchange.
Key investment considerations for AMLX include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 32.8%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 04:51 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AMLX | $13.93 | -0.9% | 1.02M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Amylyx Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW